Nebula Research & Development LLC Ocular Therapeutix, Inc Transaction History
Nebula Research & Development LLC
- $464 Billion
- Q1 2024
Shares
2 transactions
Others Institutions Holding OCUL
# of Institutions
148Shares Held
123MCall Options Held
185KPut Options Held
507K-
Summer Road LLC West Palm Beach, FL14.4MShares$98.2 Million100.0% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$87.3 Million9.97% of portfolio
-
Deep Track Capital, LP Greenwich, CT12.7MShares$87 Million3.82% of portfolio
-
Black Rock Inc. New York, NY8.06MShares$55.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.24MShares$49.5 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $526M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...